What Most Doctors Never Explain About EDS | Office Hours (Ep 204)

0:00-1:06:01

If you could listen to just one conversation about Ehlers-Danlos syndromes (EDS), hypermobility spectrum disorders (HSD), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS), what would you need to know? In this listener Q&A episode, producer Aron Korney puts host Dr. Linda Bluestein, the Hypermobility MD, in the hot seat to answer the questions patients ask most about hypermobility, connective tissue disorders, genetic testing, medications, and managing complex chronic illness. Dr. Bluestein explains why EDS, HSD, POTS, and MCAS are whole-body conditions rather than isolated joint disorders, and how connective tissue affects nearly every organ system. She shares why "less is more," why small, consistent improvements create meaningful long-term progress, and how the placebo and nocebo effects can influence healing. The conversation also covers the U.S. Food and Drug Administration (FDA) black box warning for fluoroquinolone antibiotics, including ciprofloxacin, levofloxacin, and moxifloxacin, explaining why people with connective tissue disorders should discuss safer alternatives with their healthcare providers when appropriate. Dr. Bluestein then tackles one of the most confusing topics in EDS: genetic testing.

Publisher

Bendy Bodies with Dr. Linda Bluestein

Published

July 9, 2026

Duration

1h 6m

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

Dr. Linda Bluestein

BB

Bendy Bodies with Dr. Linda Bluestein

@bendybodieswithdrlindabluest

#doctors #explain #officehours #medicine #selfimprovement

The Nile